Skip to main content
PMC home page
American Journal of Public Health logoLink to American Journal of Public Health
. 2000 Sep;90(9):1390–1392. doi: 10.2105/ajph.90.9.1390

The role of epidemiology in needle exchange programs.

D Des Vlahov 1
PMCID: PMC1447625  PMID: 10983193

Full Text

The Full Text of this article is available as a PDF (53.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Broadhead R. S., van Hulst Y., Heckathorn D. D. The impact of a needle exchange's closure. Public Health Rep. 1999 Sep-Oct;114(5):439–447. doi: 10.1093/phr/114.5.439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Brooner R., Kidorf M., King V., Beilenson P., Svikis D., Vlahov D. Drug abuse treatment success among needle exchange participants. Public Health Rep. 1998 Jun;113 (Suppl 1):129–139. [PMC free article] [PubMed] [Google Scholar]
  3. Bruneau J., Lamothe F., Franco E., Lachance N., Désy M., Soto J., Vincelette J. High rates of HIV infection among injection drug users participating in needle exchange programs in Montreal: results of a cohort study. Am J Epidemiol. 1997 Dec 15;146(12):994–1002. doi: 10.1093/oxfordjournals.aje.a009240. [DOI] [PubMed] [Google Scholar]
  4. Des Jarlais D. C., Marmor M., Paone D., Titus S., Shi Q., Perlis T., Jose B., Friedman S. R. HIV incidence among injecting drug users in New York City syringe-exchange programmes. Lancet. 1996 Oct 12;348(9033):987–991. doi: 10.1016/s0140-6736(96)02536-6. [DOI] [PubMed] [Google Scholar]
  5. Doherty M. C., Garfein R. S., Vlahov D., Junge B., Rathouz P. J., Galai N., Anthony J. C., Beilenson P. Discarded needles do not increase soon after the opening of a needle exchange program. Am J Epidemiol. 1997 Apr 15;145(8):730–737. doi: 10.1093/aje/145.8.730. [DOI] [PubMed] [Google Scholar]
  6. Hagan H., Jarlais D. C., Friedman S. R., Purchase D., Alter M. J. Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program. Am J Public Health. 1995 Nov;85(11):1531–1537. doi: 10.2105/ajph.85.11.1531. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hagan H., McGough J. P., Thiede H., Weiss N. S., Hopkins S., Alexander E. R. Syringe exchange and risk of infection with hepatitis B and C viruses. Am J Epidemiol. 1999 Feb 1;149(3):203–213. doi: 10.1093/oxfordjournals.aje.a009792. [DOI] [PubMed] [Google Scholar]
  8. Heimer R., Kaplan E. H., Khoshnood K., Jariwala B., Cadman E. C. Needle exchange decreases the prevalence of HIV-1 proviral DNA in returned syringes in New Haven, Connecticut. Am J Med. 1993 Aug;95(2):214–220. doi: 10.1016/0002-9343(93)90263-o. [DOI] [PubMed] [Google Scholar]
  9. Hurley S. F., Jolley D. J., Kaldor J. M. Effectiveness of needle-exchange programmes for prevention of HIV infection. Lancet. 1997 Jun 21;349(9068):1797–1800. doi: 10.1016/S0140-6736(96)11380-5. [DOI] [PubMed] [Google Scholar]
  10. Moss A. R. Epidemiology and the politics of needle exchange. Am J Public Health. 2000 Sep;90(9):1385–1387. doi: 10.2105/ajph.90.9.1385. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Obadia Y., Feroni I., Perrin V., Vlahov D., Moatti J. P. Syringe vending machines for injection drug users: an experiment in Marseille, France. Am J Public Health. 1999 Dec;89(12):1852–1854. doi: 10.2105/ajph.89.12.1852. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Paone D., Clark J., Shi Q., Purchase D., Des Jarlais D. C. Syringe exchange in the United States, 1996: a national profile. Am J Public Health. 1999 Jan;89(1):43–46. doi: 10.2105/ajph.89.1.43. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Paone D., Des Jarlais D. C., Gangloff R., Milliken J., Friedman S. R. Syringe exchange: HIV prevention, key findings, and future directions. Int J Addict. 1995;30(12):1647–1683. doi: 10.3109/10826089509104419. [DOI] [PubMed] [Google Scholar]
  14. Riley E. D., Safaeian M., Strathdee S. A., Marx M. A., Huettner S., Beilenson P., Vlahov D. Comparing new participants of a mobile versus a pharmacy-based needle exchange program. J Acquir Immune Defic Syndr. 2000 May 1;24(1):57–61. doi: 10.1097/00126334-200005010-00010. [DOI] [PubMed] [Google Scholar]
  15. Salomon N., Perlman D. C., Friedmann P., Ziluck V., Des Jarlais D. C. Prevalence and risk factors for positive tuberculin skin tests among active drug users at a syringe exchange program. Int J Tuberc Lung Dis. 2000 Jan;4(1):47–54. [PubMed] [Google Scholar]
  16. Schechter M. T., Strathdee S. A., Cornelisse P. G., Currie S., Patrick D. M., Rekart M. L., O'Shaughnessy M. V. Do needle exchange programmes increase the spread of HIV among injection drug users?: an investigation of the Vancouver outbreak. AIDS. 1999 Apr 16;13(6):F45–F51. doi: 10.1097/00002030-199904160-00002. [DOI] [PubMed] [Google Scholar]
  17. Strathdee S. A., Patrick D. M., Currie S. L., Cornelisse P. G., Rekart M. L., Montaner J. S., Schechter M. T., O'Shaughnessy M. V. Needle exchange is not enough: lessons from the Vancouver injecting drug use study. AIDS. 1997 Jul;11(8):F59–F65. doi: 10.1097/00002030-199708000-00001. [DOI] [PubMed] [Google Scholar]
  18. Watters J. K., Estilo M. J., Clark G. L., Lorvick J. Syringe and needle exchange as HIV/AIDS prevention for injection drug users. JAMA. 1994 Jan 12;271(2):115–120. [PubMed] [Google Scholar]
  19. van Ameijden E. J., van den Hoek J. A., van Haastrecht H. J., Coutinho R. A. The harm reduction approach and risk factors for human immunodeficiency virus (HIV) seroconversion in injecting drug users, Amsterdam. Am J Epidemiol. 1992 Jul 15;136(2):236–243. doi: 10.1093/oxfordjournals.aje.a116489. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Public Health are provided here courtesy of American Public Health Association

RESOURCES